// company-profile

Monopar Therapeutics

MNPR
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings87Insiders17
// api This Monopar Therapeutics insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Monopar Therapeutics insiders bought $0 (4 transactions) and sold $194K (2 transactions).

  • Most active insider: Robinson Chandler with 3 transactions totaling $108K.
  • Largest single sale: $108K by Robinson Chandler on Mar 31, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Monopar Therapeutics as of 2026-03-31

— stable
Total reported AUM
$334.6M
QoQ change
-2.1%
Reporting period
2026-03-31
#1
JANUS HENDERSON GROUP PLC
CIK 1274173
$72.1M
1.3M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$36.6M
667K shares
#3
Saturn V Capital Management LP
CIK 1964437
$18.9M
346K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Mar 31, 2026Robinson ChandlerMNPR
Option Exercise
6,732
Mar 31, 2026Cittadine AndrewMNPR
Option Exercise
3,514$0.00$0K
Mar 31, 2026Robinson ChandlerMNPR
Tax Withholding
1,972$54.79$108K
Mar 31, 2026Cittadine AndrewMNPR
Option Exercise
3,514
Mar 31, 2026Cittadine AndrewMNPR
Tax Withholding
1,571$54.79$86K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.